The landscape of dementia analysis has progressed considerably with the advent of complex biomarkers, such as amyloid PET scans, tau imaging, and blood-dependent checks that may detect Alzheimer's pathology several years before signs arise. While these technological developments depict extraordinary progress in comprehension neurodegenerative disor